Search for other papers by Rony Ruben in
Google Scholar
PubMed
Search for other papers by Praveen V. Pavithran in
Google Scholar
PubMed
Search for other papers by V. Usha Menon in
Google Scholar
PubMed
Search for other papers by Vasantha Nair in
Google Scholar
PubMed
Search for other papers by Harish Kumar in
Google Scholar
PubMed
necessary to predict the risk of persistence or recurrence of disease after initial therapy seen in about 12–29% [ 3 , 4 ]. In 1996, the American Thyroid Association (ATA) published treatment guidelines for patients with thyroid nodules and DTC [ 5
Search for other papers by Jiahui Wu in
Google Scholar
PubMed
Search for other papers by Xunyang Hu in
Google Scholar
PubMed
Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Paula Seal in
Google Scholar
PubMed
Search for other papers by Parthiv Amin in
Google Scholar
PubMed
Mayfair Radiology, Calgary, Alberta, Canada
Search for other papers by Brendan Diederichs in
Google Scholar
PubMed
Departments of Medicine, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
. IRG implemented a predetermined list of terms in a dropdown menu and required fields for each nodule characteristic and the malignancy risk classification. The purpose of these changes was to standardize and accelerate the reporting process in
Search for other papers by Nicholas S. Andresen in
Google Scholar
PubMed
Search for other papers by John M. Buatti in
Google Scholar
PubMed
Search for other papers by Hamed H. Tewfik in
Google Scholar
PubMed
Search for other papers by Nitin A. Pagedar in
Google Scholar
PubMed
Search for other papers by Carryn M. Anderson in
Google Scholar
PubMed
Search for other papers by John M. Watkins in
Google Scholar
PubMed
by dose level The long-term toxicities of RAI include secondary primary malignancy (SPM) [ 51 - 57 ], sialoadenitis [ 58 ], nasolacrimal duct obstruction [ 59 ], and infertility [ 60 ]. The increased risk of primary malignancy in thyroid
Search for other papers by Jan Jiskra in
Google Scholar
PubMed
Search for other papers by Jiří Horáček in
Google Scholar
PubMed
Search for other papers by Sylvie Špitálníková in
Google Scholar
PubMed
Search for other papers by Jan Paleček in
Google Scholar
PubMed
Search for other papers by Zdeňka Límanová in
Google Scholar
PubMed
Search for other papers by Jan Krátký in
Google Scholar
PubMed
Search for other papers by Drahomíra Springer in
Google Scholar
PubMed
Search for other papers by Kristýna Žabková in
Google Scholar
PubMed
Search for other papers by Hana Vítková in
Google Scholar
PubMed
ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS . European Thyroid Journal 2017 6 225 – 237 . ( https://doi.org/10.1159/000478927 ) 15 Haugen BR Alexander EK Bible KC Doherty GM Mandel SJ Nikiforov YE
Search for other papers by Samuel Chan in
Google Scholar
PubMed
Search for other papers by Katarina Karamali in
Google Scholar
PubMed
Search for other papers by Anna Kolodziejczyk in
Google Scholar
PubMed
Search for other papers by Georgios Oikonomou in
Google Scholar
PubMed
Search for other papers by John Watkinson in
Google Scholar
PubMed
Search for other papers by Vinidh Paleri in
Google Scholar
PubMed
Search for other papers by Iain Nixon in
Google Scholar
PubMed
Search for other papers by Dae Kim in
Google Scholar
PubMed
Introduction The incidence of well-differentiated thyroid cancer (DTC) is increasing faster than any other malignancies and estimated to increase by 30% by 2022 [ 1 ]. Most new cases are less than 4-cm tumours (T1–2), often diagnosed early due
Search for other papers by Dorinda Mullen in
Google Scholar
PubMed
Search for other papers by Sarah Mullins in
Google Scholar
PubMed
Search for other papers by Aoife Doyle in
Google Scholar
PubMed
School of Medicine and Medical Sciences, University College Dublin, Dublin 4, Ireland
Search for other papers by Rachel K. Crowley in
Google Scholar
PubMed
School of Medicine and Medical Sciences, University College Dublin, Dublin 4, Ireland
Search for other papers by Stephen Skehan in
Google Scholar
PubMed
School of Medicine and Medical Sciences, University College Dublin, Dublin 4, Ireland
Search for other papers by Enda W. McDermott in
Google Scholar
PubMed
School of Medicine and Medical Sciences, University College Dublin, Dublin 4, Ireland
Search for other papers by Ruth S. Prichard in
Google Scholar
PubMed
School of Medicine and Medical Sciences, University College Dublin, Dublin 4, Ireland
Search for other papers by David Gibbons in
Google Scholar
PubMed
categories, and so it is not possible to classify with confidence whether a lesion is benign, suspicious for malignancy, or malignant. The clinical management of these lesions is very difficult due to this undetermined risk of malignancy. The introduction
Department of Endocrinology, Portuguese Institute of Oncology, Lisbon, Portugal
Search for other papers by Mafalda Marcelino in
Google Scholar
PubMed
Search for other papers by Pedro Marques in
Google Scholar
PubMed
Search for other papers by Luis Lopes in
Google Scholar
PubMed
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Search for other papers by João Jácome de Castro in
Google Scholar
PubMed
significantly higher than usually assumed (3% [ 10 ] vs. 18% [ 11 ]). Cerci et al. [ 12 ] found no significant difference in the incidence of thyroid cancer between TMNG and nontoxic multinodular goiter (MNG). The risk of malignancy in Graves' disease might be
Search for other papers by L.A. Jonker in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Search for other papers by C.A. Lebbink in
Google Scholar
PubMed
Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by M.C.J. Jongmans in
Google Scholar
PubMed
Department of Pediatric Radiology and Nuclear Medicine, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by R.A.J. Nievelstein in
Google Scholar
PubMed
Search for other papers by J.H.M. Merks in
Google Scholar
PubMed
Search for other papers by E.J.M. Nieveen van Dijkum in
Google Scholar
PubMed
Search for other papers by T.P. Links in
Google Scholar
PubMed
Search for other papers by N. Hoogerbrugge in
Google Scholar
PubMed
Search for other papers by A.S.P. van Trotsenburg in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Search for other papers by H.M. van Santen in
Google Scholar
PubMed
– activity which is undesirable in young patients and in patients at risk for secondary malignancies [ 20 ]. Based on these arguments, the national expert panel recommends surveillance for DTC in children with PHTS to enable detection of DTC in an early
Search for other papers by F. Cecoli in
Google Scholar
PubMed
Search for other papers by E.M. Ceresola in
Google Scholar
PubMed
Search for other papers by V. Altrinetti in
Google Scholar
PubMed
Search for other papers by M. Cabria in
Google Scholar
PubMed
Search for other papers by M. Cappagli in
Google Scholar
PubMed
Search for other papers by A. Montepagani in
Google Scholar
PubMed
Search for other papers by C.M. Cuttica in
Google Scholar
PubMed
Search for other papers by U. Filippi in
Google Scholar
PubMed
Search for other papers by D. Saverino in
Google Scholar
PubMed
Search for other papers by M. Raffa in
Google Scholar
PubMed
Search for other papers by M. Caputo in
Google Scholar
PubMed
Search for other papers by F. Minuto in
Google Scholar
PubMed
Search for other papers by M. Giusti in
Google Scholar
PubMed
Search for other papers by M. Bagnasco in
Google Scholar
PubMed
iodine (RAI), there is agreement that patients with very-low-risk thyroid cancers (≤1 cm confined to the thyroid) do not require RAI. In addition, the TSH goal is a matter of debate [ 18 ]. According to the latest ATA guidelines [ 11 ], in patients free
Search for other papers by Julia A Baran in
Google Scholar
PubMed
Search for other papers by Mya Bojarsky in
Google Scholar
PubMed
Search for other papers by Stephen Halada in
Google Scholar
PubMed
Search for other papers by Julio C Ricarte-Filho in
Google Scholar
PubMed
Search for other papers by Amber Isaza in
Google Scholar
PubMed
Search for other papers by Aime T Franco in
Google Scholar
PubMed
Search for other papers by Lea F Surrey in
Google Scholar
PubMed
Search for other papers by Tricia Bhatti in
Google Scholar
PubMed
Search for other papers by Zubair Baloch in
Google Scholar
PubMed
Search for other papers by N Scott Adzick in
Google Scholar
PubMed
Division of Oncology, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
Search for other papers by Sogol Mostoufi-Moab in
Google Scholar
PubMed
Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Search for other papers by Ken Kazahaya in
Google Scholar
PubMed
Search for other papers by Andrew J Bauer in
Google Scholar
PubMed
data demonstrating a high rate of metastasis (30–90%) ( 6 , 7 ) to regional lymph nodes (LNs) in the pediatric population and was used to stratify patients into ATA risk levels for selective use of radioiodine therapy (RAIT; Recommendation 15) ( 5 , 8